JW Lifescience Corporation (234080.KS) KSC

13,400.00

-200(-1.47%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap168.48B
Enterprise Value230.2B
P/E Ratio4.35
PEG Ratio-1.14
Price/Sales Ratio0.84
Price/Book Ratio0.96
Enterprise/Revenue1
Enterprise/EBITDA2.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.19
Operating Margin0.14

Management Effectiveness

Return On Assets0.15
Return On Equity0.23

Income Statement

Revenue222.48B
Revenue/Share16,074.1
Gross Profit57.51B
EBITDA76.82B
Net Income43.99B
Diluted EPS2,842.77

Balance Sheet

Total Cash25.8B
Total Cash/Share1,669.91
Total Debt48.85B
Total Debt/Equity0.23
Current Ratio1.21
Book Value Per Share13,909.21

Price History

52-Week Change17.85
52-Week High15,580
52-Week Low10,000
Moving Average 50 Days14,034.2
Moving Average 200 Days12,453.35

Statistics

Average Volume107,486
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield3.73
Payout Ratio0.16
Last Split Factor2:1
Last Split DateMay 15, 2018